.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Argus Health
Deloitte
Covington
Cantor Fitzgerald
Chubb
McKesson
Express Scripts
Moodys
UBS

Generated: June 23, 2017

DrugPatentWatch Database Preview

OMNIPRED Drug Profile

« Back to Dashboard

Which patents cover Omnipred, and what generic Omnipred alternatives are available?

Omnipred is a drug marketed by Novartis Pharms Corp and is included in one NDA.

The generic ingredient in OMNIPRED is prednisolone acetate. There are eighty-five drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the prednisolone acetate profile page.

Summary for Tradename: OMNIPRED

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Bulk Api Vendors: see list41
Clinical Trials: see list1
Patent Applications: see list2,102
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OMNIPRED at DailyMed

Pharmacology for Tradename: OMNIPRED

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp
OMNIPRED
prednisolone acetate
SUSPENSION/DROPS;OPHTHALMIC017469-001Approved Prior to Jan 1, 1982ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Johnson and Johnson
Chinese Patent Office
Cipla
Fish and Richardson
Cerilliant
Deloitte
Teva
Julphar
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot